Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: from JT's note

I would prefer a PR (in the earnings announcement) to hit the street with an earnings guidance number for the next qtr. It doesn't have to be 100% current (with enough ambigutity to avoid any disclosure concerns), but enough to reflect a strong growth from the just released qtr. The point is to get the message out for that shareholder value we're missing out on til this revenue stream gets it butt off the ground.

I don't know if my crunching numbers post would help any of your work.

http://agoracom.com/ir/patriot/messages/676240#message

Regards

Share
New Message
Please login to post a reply